Myelodysplastic syndrome is a malignant disease originating from bone marrow hematopoietic stem cells, and the cost of treatment is high, in the range of 200,000 to 500,000 yuan.
At present, the clinical treatment of bone marrow hematopoietic stem cells mainly includes drug therapy and stem cell transplantation.
1. Drug therapy: It mainly includes demethylation therapy and chemotherapy (decitabine, cytarabine), in addition to blood transfusion, hemostasis (tranexamic acid) and other treatments, which cost more, and anti-infection treatment (levofloxacin) is also needed in case of infections, and it will cost even more if high-level antibiotics are used. Drugs usually cost about 30,000 to 100,000 yuan.
2. Hematopoietic stem cell transplantation: Usually, the operation costs about 200,000-350,000 RMB, and after the operation, anti-rejection drugs (tacrolimus, cyclosporine) are needed, which cost about 50,000-100,000 RMB.
The specific cost of treatment is recommended to refer to the local tertiary hospital charges, different local charges, the price difference is also large. The use of drugs should be under the guidance of a physician.